SynthesisFrontiers in medicine2023

A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19.

Wuxia Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.